ZVIA Fundamental Analysis - ZEVIA PBC-A

Name: ZEVIA PBC-A (ZVIA) Stock
Brand: ZEVIA PBC-A
Rating: 5.5 (3 reviews)

Fundamental Rating

Overall ZVIA gets a fundamental rating of 4 out of 10. We evaluated ZVIA against 33 industry peers in the Beverages industry. ZVIA has a great financial health rating, but its profitability evaluates not so good. ZVIA is valied quite expensively at the moment, while it does show a decent growth rate.

Quickly go to:

1. Profitability

1.1 Basic Checks

ZVIA had negative earnings in the past year.

In the past year ZVIA has reported a negative cash flow from operations.

ZVIA had negative earnings in each of the past 5 years.

In the past 5 years ZVIA always reported negative operating cash flow.

1.2 Ratios

Looking at the Return On Assets, with a value of -22.76%, ZVIA is doing worse than 84.85% of the companies in the same industry.

The Return On Equity of ZVIA (-26.81%) is worse than 84.85% of its industry peers.

		Industry Rank	Sector Rank
ROA	-22.76%
ROE	-26.81%
ROIC	N/A

ROA(3y)-29.12%

ROA(5y)-27.27%

ROE(3y)-28.52%

ROE(5y)-27.7%

ROIC(3y)N/A

ROIC(5y)N/A

1.3 Margins

Looking at the Gross Margin, with a value of 49.25%, ZVIA is in line with its industry, outperforming 54.55% of the companies in the same industry.

In the last couple of years the Gross Margin of ZVIA has remained more or less at the same level.

ZVIA does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.

		Industry Rank	Sector Rank
OM	N/A
PM (TTM)	N/A
GM	49.25%

OM growth 3YN/A

OM growth 5YN/A

PM growth 3YN/A

PM growth 5YN/A

GM growth 3Y1.56%

GM growth 5Y1.48%

More info and screens

ROA

ROE

ROIC

Operating and Profit Margin

Show most profitable peers

2. Health

2.1 Basic Checks

ZVIA does not have a ROIC to compare to the WACC, probably because it is not profitable.

ZVIA has more shares outstanding than it did 1 year ago.

Compared to 5 years ago, ZVIA has more shares outstanding

There is no outstanding debt for ZVIA. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.

2.2 Solvency

ZVIA has an Altman-Z score of 12.05. This indicates that ZVIA is financially healthy and has little risk of bankruptcy at the moment.

Looking at the Altman-Z score, with a value of 12.05, ZVIA belongs to the top of the industry, outperforming 90.91% of the companies in the same industry.

ZVIA has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.

		Industry Rank	Sector Rank
Debt/Equity	0
Debt/FCF	N/A
Altman-Z	12.05

ROIC/WACCN/A

WACC8.77%

2.3 Liquidity

ZVIA has a Current Ratio of 2.34. This indicates that ZVIA is financially healthy and has no problem in meeting its short term obligations.

ZVIA has a Current ratio of 2.34. This is in the better half of the industry: ZVIA outperforms 75.76% of its industry peers.

A Quick Ratio of 1.69 indicates that ZVIA should not have too much problems paying its short term obligations.

With an excellent Quick ratio value of 1.69, ZVIA belongs to the best of the industry, outperforming 84.85% of the companies in the same industry.

		Industry Rank	Sector Rank
Current Ratio	2.34
Quick Ratio	1.69

More info and screens

WACC

Debt/Equity

How to determine the health of a company

Altman-Z score

Show peers with great health

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 51.35% over the past year.

ZVIA shows a decrease in Revenue. In the last year, the revenue decreased by -6.83%.

The Revenue has been growing by 12.62% on average over the past years. This is quite good.

EPS 1Y (TTM)51.35%

EPS 3YN/A

EPS 5YN/A

EPS Q2Q%0%

Revenue 1Y (TTM)-6.83%

Revenue growth 3Y3.91%

Revenue growth 5Y12.62%

Sales Q2Q%12.31%

3.2 Future

Based on estimates for the next years, ZVIA will show a very strong growth in Earnings Per Share. The EPS will grow by 21.70% on average per year.

Based on estimates for the next years, ZVIA will show a small growth in Revenue. The Revenue will grow by 6.26% on average per year.

EPS Next Y45.16%

EPS Next 2Y28.84%

EPS Next 3Y21.7%

EPS Next 5YN/A

Revenue Next Year4.41%

Revenue Next 2Y5.54%

Revenue Next 3Y6.26%

Revenue Next 5YN/A

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.

More info and screens

Find the best growth stocks

Show best growing peers

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for ZVIA. In the last year negative earnings were reported.

Also next year ZVIA is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.

		Industry Rank	Sector Rank
PE	N/A
Fwd PE	N/A

4.2 Price Multiples

		Industry Rank	Sector Rank
P/FCF	N/A
EV/EBITDA	N/A

4.3 Compensation for Growth

ZVIA's earnings are expected to grow with 21.70% in the coming years. This may justify a more expensive valuation.

PEG (NY)N/A

PEG (5Y)N/A

EPS Next 2Y28.84%

EPS Next 3Y21.7%

More info and screens

Show best valued peers

5. Dividend

5.1 Amount

No dividends for ZVIA!.

		Industry Rank	Sector Rank
Dividend Yield	N/A

More info and screens

Find the best dividend stocks

Show peers with best dividend

ZEVIA PBC-A

NYSE:ZVIA (11/11/2025, 5:16:23 PM)

After market: 2.7 0 (0%)

2.7

+0.09 (+3.45%)

Chartmill FA Rating

GICS SectorConsumer Staples

GICS IndustryGroupFood, Beverage & Tobacco

GICS IndustryBeverages

Earnings (Last)11-05 2025-11-05/amc

Earnings (Next)N/A N/A

Inst Owners58.97%

Inst Owner Change0.1%

Ins Owners4.75%

Ins Owner Change-3.55%

Market Cap202.37M

Revenue(TTM)155.05M

Net Income(TTM)-14.21M

Analysts80

Price Target4.73 (75.19%)

Short Float %2.74%

Short Ratio1.99

Dividend

		Industry Rank	Sector Rank
Dividend Yield	N/A

Yearly DividendN/A

Dividend Growth(5Y)N/A

DPN/A

Div Incr Years0

Div Non Decr Years0

Ex-DateN/A

Surprises & Revisions

EPS beat(2)2

Avg EPS beat(2)65.88%

Min EPS beat(2)54.05%

Max EPS beat(2)77.72%

EPS beat(4)3

Avg EPS beat(4)42.41%

Min EPS beat(4)-12.04%

Max EPS beat(4)77.72%

EPS beat(8)7

Avg EPS beat(8)24.73%

EPS beat(12)11

Avg EPS beat(12)31.24%

EPS beat(16)13

Avg EPS beat(16)8.88%

Revenue beat(2)2

Avg Revenue beat(2)2.47%

Min Revenue beat(2)0.34%

Max Revenue beat(2)4.61%

Revenue beat(4)2

Avg Revenue beat(4)-1.47%

Min Revenue beat(4)-9.04%

Max Revenue beat(4)4.61%

Revenue beat(8)4

Avg Revenue beat(8)-0.21%

Revenue beat(12)6

Avg Revenue beat(12)-0.16%

Revenue beat(16)7

Avg Revenue beat(16)-0.71%

PT rev (1m)-4.66%

PT rev (3m)4.08%

EPS NQ rev (1m)-1.33%

EPS NQ rev (3m)-58.32%

EPS NY rev (1m)0.5%

EPS NY rev (3m)-8.23%

Revenue NQ rev (1m)0.17%

Revenue NQ rev (3m)-2.93%

Revenue NY rev (1m)0%

Revenue NY rev (3m)0.68%

Valuation

		Industry Rank	Sector Rank
PE	N/A
Fwd PE	N/A
P/S	1.28
P/FCF	N/A
P/OCF	N/A
P/B	3.82
P/tB	4.05
EV/EBITDA	N/A

EPS(TTM)-0.18

EYN/A

EPS(NY)-0.11

Fwd EYN/A

FCF(TTM)-0.04

FCFYN/A

OCF(TTM)-0.03

OCFYN/A

SpS2.11

BVpS0.71

TBVpS0.67

PEG (NY)N/A

PEG (5Y)N/A

Graham NumberN/A

Profitability

		Industry Rank	Sector Rank
ROA	-22.76%
ROE	-26.81%
ROCE	N/A
ROIC	N/A
ROICexc	N/A
ROICexgc	N/A
OM	N/A
PM (TTM)	N/A
GM	49.25%
FCFM	N/A

ROA(3y)-29.12%

ROA(5y)-27.27%

ROE(3y)-28.52%

ROE(5y)-27.7%

ROIC(3y)N/A

ROIC(5y)N/A

ROICexc(3y)N/A

ROICexc(5y)N/A

ROICexgc(3y)N/A

ROICexgc(5y)N/A

ROCE(3y)N/A

ROCE(5y)N/A

ROICexgc growth 3YN/A

ROICexgc growth 5YN/A

ROICexc growth 3YN/A

ROICexc growth 5YN/A

OM growth 3YN/A

OM growth 5YN/A

PM growth 3YN/A

PM growth 5YN/A

GM growth 3Y1.56%

GM growth 5Y1.48%

F-Score5

Asset Turnover2.54

Health

		Industry Rank	Sector Rank
Debt/Equity	0
Debt/FCF	N/A
Debt/EBITDA	N/A
Cap/Depr	21.64%
Cap/Sales	0.15%
Interest Coverage	N/A
Cash Conversion	N/A
Profit Quality	N/A
Current Ratio	2.34
Quick Ratio	1.69
Altman-Z	12.05

F-Score5

WACC8.77%

ROIC/WACCN/A

Cap/Depr(3y)104.57%

Cap/Depr(5y)142.96%

Cap/Sales(3y)0.92%

Cap/Sales(5y)1.15%

Profit Quality(3y)N/A

Profit Quality(5y)N/A

High Growth Momentum

Growth

EPS 1Y (TTM)51.35%

EPS 3YN/A

EPS 5YN/A

EPS Q2Q%0%

EPS Next Y45.16%

EPS Next 2Y28.84%

EPS Next 3Y21.7%

EPS Next 5YN/A

Revenue 1Y (TTM)-6.83%

Revenue growth 3Y3.91%

Revenue growth 5Y12.62%

Sales Q2Q%12.31%

Revenue Next Year4.41%

Revenue Next 2Y5.54%

Revenue Next 3Y6.26%

Revenue Next 5YN/A

EBIT growth 1Y60.76%

EBIT growth 3YN/A

EBIT growth 5YN/A

EBIT Next Year60.09%

EBIT Next 3Y30.65%

EBIT Next 5YN/A

FCF growth 1Y2.72%

FCF growth 3YN/A

FCF growth 5YN/A

OCF growth 1Y-1406.88%

OCF growth 3YN/A

OCF growth 5YN/A

ZEVIA PBC-A / ZVIA FAQ

What is the ChartMill fundamental rating of ZEVIA PBC-A (ZVIA) stock?

ChartMill assigns a fundamental rating of 4 / 10 to ZVIA.

What is the valuation status of ZEVIA PBC-A (ZVIA) stock?

ChartMill assigns a valuation rating of 1 / 10 to ZEVIA PBC-A (ZVIA). This can be considered as Overvalued.

What is the profitability of ZVIA stock?

ZEVIA PBC-A (ZVIA) has a profitability rating of 1 / 10.

ZEVIA PBC-A (ZVIA) Stock Fundamental Analysis

1. Profitability

1.1 Basic Checks

1.2 Ratios

1.3 Margins

More info and screens

2. Health

2.1 Basic Checks

2.2 Solvency

2.3 Liquidity

More info and screens

3. Growth

3.1 Past

3.2 Future

3.3 Evolution

More info and screens

4. Valuation

4.1 Price/Earnings Ratio

4.2 Price Multiples

4.3 Compensation for Growth

More info and screens

5. Dividend

5.1 Amount

More info and screens

ZEVIA PBC-A / ZVIA FAQ

What is the ChartMill fundamental rating of ZEVIA PBC-A (ZVIA) stock?

What is the valuation status of ZEVIA PBC-A (ZVIA) stock?

What is the profitability of ZVIA stock?